Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenues: | |||||||||||||||||||||
product sales | 118,697,000 | 102,660,000 | 78,335,000 | 66,408,000 | 48,118,000 | 40,813,000 | 24,720,000 | 13,076,000 | 1,653,000 | ||||||||||||
license fees and collaboration revenue | 2,894,000 | 218,000 | 2,500,000 | ||||||||||||||||||
total revenues | 118,697,000 | 102,660,000 | 78,335,000 | 66,408,000 | 48,118,000 | 40,813,000 | 27,614,000 | 13,076,000 | 1,871,000 | 10,000,000 | 15,277,000 | 539,000 | 338,000 | 1,240,000 | 22,017,000 | 33,432,000 | |||||
operating expenses: | |||||||||||||||||||||
cost of sales | 8,309,000 | 6,237,000 | 5,211,000 | 4,926,000 | 3,242,000 | 3,004,000 | 1,654,000 | 1,216,000 | 377,000 | ||||||||||||
gross profit | |||||||||||||||||||||
yoy | |||||||||||||||||||||
qoq | |||||||||||||||||||||
gross margin % | |||||||||||||||||||||
research and development | 16,284,000 | 15,594,000 | 14,409,000 | 16,873,000 | 12,128,000 | 12,319,000 | 12,066,000 | 13,305,000 | 12,105,000 | 12,546,000 | 12,356,000 | 10,028,000 | 10,912,000 | 9,603,000 | 12,081,000 | 8,038,000 | 10,209,000 | 7,204,000 | 16,261,000 | 7,587,000 | 7,991,000 |
selling, general and administrative | 108,633,000 | 103,013,000 | 84,995,000 | 69,030,000 | 57,910,000 | 58,792,000 | 51,578,000 | 43,005,000 | 30,324,000 | ||||||||||||
total operating expenses | 133,226,000 | 124,844,000 | 104,615,000 | 90,829,000 | 73,280,000 | 74,115,000 | 65,298,000 | 57,526,000 | 42,806,000 | 32,821,000 | 27,452,000 | 25,061,000 | 22,906,000 | 20,501,000 | 20,060,000 | 14,786,000 | 16,945,000 | 14,735,000 | 22,718,000 | 11,477,000 | 10,141,000 |
income from operations before other income | -14,529,000 | -22,184,000 | -26,280,000 | -24,037,000 | -25,162,000 | -33,302,000 | -37,684,000 | ||||||||||||||
other income: | |||||||||||||||||||||
interest income | 4,114,000 | 4,229,000 | 3,454,000 | 3,647,000 | 4,120,000 | 4,130,000 | 3,117,000 | 2,978,000 | 2,840,000 | 2,226,000 | 2,293,000 | 2,127,000 | 1,061,000 | -247,000 | -316,000 | 12,000 | 8,000 | 7,000 | 9,000 | 10,000 | 4,000 |
interest expense | -2,268,000 | -2,240,000 | -2,213,000 | -2,312,000 | -2,445,000 | -2,109,000 | -983,000 | -989,000 | -858,000 | -815,000 | -684,000 | -692,000 | -633,000 | ||||||||
loss on debt extinguishment | -1,944,000 | ||||||||||||||||||||
other income | 98,000 | -145,000 | -81,000 | -27,000 | 67,000 | -59,000 | 605,000 | -13,000 | -48,000 | -47,000 | 6,000 | -50,000 | -7,000 | 106,000 | 37,000 | -5,000 | 5,000 | -39,000 | -34,000 | ||
total other income | 1,944,000 | 1,844,000 | 1,160,000 | 1,308,000 | 1,742,000 | 12,000 | 1,953,000 | 2,548,000 | 1,787,000 | 1,397,000 | 1,533,000 | 1,462,000 | 390,000 | -519,000 | -716,000 | -349,000 | -333,000 | -908,000 | -25,000 | 10,000 | 4,000 |
net income | -12,585,000 | -20,340,000 | -25,120,000 | -23,113,000 | -23,420,000 | -33,290,000 | -35,731,000 | -41,902,000 | -39,148,000 | -31,424,000 | -23,419,000 | -13,599,000 | -22,511,000 | ||||||||
yoy | -46.26% | -38.90% | -29.70% | -44.84% | -40.18% | 5.94% | 52.57% | 208.13% | 73.91% | ||||||||||||
qoq | -38.13% | -19.03% | 8.68% | -1.31% | -29.65% | -6.83% | -14.73% | 7.03% | 24.58% | 34.18% | 72.21% | -39.59% | |||||||||
net income margin % | |||||||||||||||||||||
unrealized gain on marketable securities and cash equivalents | 250,000 | -46,000 | -94,000 | -167,000 | 522,000 | -113,000 | -61,000 | 6,000 | 15,000 | 47,000 | 4,000 | ||||||||||
comprehensive loss | -12,335,000 | -20,386,000 | -25,214,000 | -23,280,000 | -22,898,000 | -33,403,000 | -35,792,000 | -41,896,000 | -39,133,000 | -31,377,000 | -23,415,000 | ||||||||||
net income per share | -0.3 | -0.48 | -0.64 | -0.59 | -0.61 | -0.88 | -1.01 | -1.27 | -1.28 | -1.17 | -0.88 | -0.49 | -0.84 | -0.24 | -0.98 | 1.41 | -3.71 | ||||
weighted-average shares outstanding, basic and diluted | 42,607,717 | 42,360,452 | 39,345,359 | 37,604,538 | 38,381,968 | 37,823,233 | 35,300,655 | 29,383,276 | 30,622,440 | 24,619,700 | |||||||||||
realized/unrealized loss on equity investments | -147,750 | ||||||||||||||||||||
change in fair value of equity warrants issued by licensee | -201,000 | 152,000 | -36,000 | 18,000 | -17,000 | 19,000 | -18,000 | -257,000 | |||||||||||||
other comprehensive gain: | |||||||||||||||||||||
realized/unrealized gain on equity investments | -6,000 | ||||||||||||||||||||
other comprehensive loss: | |||||||||||||||||||||
unrealized loss on equity investments | -585,000 | -40,250 | -111,000 | -65,000 | 58,000 | -13,000 | -121,000 | ||||||||||||||
cost of license fees and collaboration revenue | 400,000 | 522,000 | 33,000 | -24,000 | 65,000 | 737,000 | 1,297,000 | ||||||||||||||
income from operations before other income and income taxes | -24,677,000 | -40,935,000 | -32,821,000 | -24,952,000 | -15,061,000 | -22,906,000 | -5,224,000 | -19,521,000 | -14,448,000 | -15,705,000 | 7,282,000 | 10,714,000 | -11,477,000 | -10,141,000 | |||||||
benefit from income taxes | -29,000 | -313,000 | -1,000 | ||||||||||||||||||
general and administrative | 20,275,000 | 15,096,000 | 14,633,000 | 11,994,000 | 10,376,000 | 7,946,000 | 6,772,000 | 6,671,000 | 6,794,000 | 5,160,000 | 3,890,000 | 2,150,000 | |||||||||
unrealized gain on equity investments | 15,000 | ||||||||||||||||||||
weighted-average shares outstanding, basic | 26,815,733 | 26,742,023 | 26,662,374 | 24,332,531 | 20,710,224 | ||||||||||||||||
weighted-average shares outstanding, diluted | 26,815,733 | 26,742,023 | 26,662,374 | 24,332,531 | 20,710,224 | ||||||||||||||||
license fees | 10,000,000 | 13,893,000 | 708,000 | 19,048,000 | 33,311,000 | ||||||||||||||||
collaboration revenue | 1,384,000 | 539,000 | 338,000 | 532,000 | 2,969,000 | 121,000 | |||||||||||||||
benefit for income taxes | 5,000 | -1,000 | -250 | 341,000 | |||||||||||||||||
other comprehensive income: | |||||||||||||||||||||
unrealized loss on marketable securities and cash equivalents | -64,000 | -10,000 | |||||||||||||||||||
comprehensive income | -12,125,500 | -22,521,000 | |||||||||||||||||||
net income and comprehensive income | -5,743,000 | -20,238,000 | 256,000 | -15,697,000 | 6,345,000 | 10,376,000 | |||||||||||||||
unrealized loss on equity securities | -192,000 | ||||||||||||||||||||
change in fair value of equity warrants | -245,000 | ||||||||||||||||||||
net (loss) per share, basic | -0.98 | ||||||||||||||||||||
change in fair value of equity warrant rights | -305,500 | -346,000 | -876,000 | ||||||||||||||||||
net income per share | -0.3 | -0.48 | -0.64 | -0.59 | -0.61 | -0.88 | -1.01 | -1.27 | -1.28 | -1.17 | -0.88 | -0.49 | -0.84 | -0.24 | -0.98 | 1.41 | -3.71 | ||||
basic | 0.013 | -0.76 | 0.31 | 0.51 | |||||||||||||||||
diluted | 0.013 | -0.76 | 0.29 | 0.47 | |||||||||||||||||
weighted-average shares outstanding | |||||||||||||||||||||
basic | 20,641,285 | 20,555,258 | 20,336,022 | ||||||||||||||||||
diluted | 20,641,285 | 21,966,599 | 21,824,574 | ||||||||||||||||||
change in fair value of derivative liabilities | |||||||||||||||||||||
net income and comprehensive loss | -11,467,000 | -10,138,000 | |||||||||||||||||||
weighted-average common shares outstanding, basic and diluted | 2,729,685 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
